COMMON STOCK PURCHASE WARRANT NEXIEN BIOPHARMA, INC.Nexien Biopharma, Inc. • January 21st, 2022 • Pharmaceutical preparations • Florida
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the funding of that certain secured convertible promissory note dated January 18, 2022, in the original principal amount of $170,454 issued by the Company (as defined below) to the Lender (as defined below) (the “Note”), Quick Capital, LLC, a Wyoming limited liability company (the “Lender” and including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the Exercise Period, to purchase from NEXIEN BIOPHARMA, INC., a Delaware corporation (the “Company”), 347,512 shares of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price per share then in effect. The number of Warrant Shares for which this Warrant may be exercised is subject to adjustment in accordance with the terms hereof. This Warrant is issued by the Company as of the Is
NOTE PURCHASE AGREEMENTNote Purchase Agreement • January 21st, 2022 • Nexien Biopharma, Inc. • Pharmaceutical preparations • Florida
THIS NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of January 18, 2022, (the “Execution Date”), is entered into by and between NEXIEN BIOPHARMA, INC., a Delaware corporation (the “Company”), and QUICK CAPITAL, LLC, a Wyoming limited liability company (the “Buyer”). Each capitalized term used herein shall have the meaning ascribed thereto in Section 10 below, or as otherwise defined herein.
